Hanmi in South Korea
Web: https://www.hanmipharm.com/
Addresses:
-
Pyeongtaek Plant Hanmi in South Korea
114, Chupalsandan-ro, Paengseong-eup, Pyeongtaek-si, Gyeonggi-do, Korea
Phone: +82-31-8053-1000
Fax: +80-31-8053-1111
-
Office Hanmi in South Korea
14, Wiryeseong-daero, Songpa-gu, Seoul, Korea
Phone: +82-2-410-9114
Fax: +82-2-410-9259
-
Paltan Plant Hanmi in South Korea
214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do, Korea
Phone: +82-31-350-5600
Fax: +82-31-356-5151
-
R&D Center Hanmi in South Korea
550, Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Korea
Phone: +82-31-371-5114
Fax: +82-31-371-5119
Clinical Trials sponsored by Hanmi
-
Hanmi Pharmaceutical Company LimitedNot yet recruiting
-
Hanmi Pharmaceutical Company LimitedNot yet recruiting
-
Hanmi Pharmaceutical Company LimitedNot yet recruiting
-
Hanmi Pharmaceutical Company LimitedRecruitingNASH - Nonalcoholic SteatohepatitisKorea, Republic of, United States
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Hanmi Pharmaceutical Company LimitedCompletedHypertensionKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedRenal ImpairmentUnited States
-
Hanmi Pharmaceutical Company LimitedCompletedHypertensionKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedHypertensionKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedHypertensionKorea, Republic of
About Hanmi
Hanmi Pharmaceutical jumps up to be a global leading pharmaceutical company with development of new biologics, new chemical entities, and innovative new drugs. The slogan of Hanmi is 'creation and challenge' as Hanmi tries to make new ways for the domestic pharmaceutical market. We have started a distribution revolution with RFID technology,the nation's very first success of US expansion with IMD, and R&D collaboration with global companies. Hanmi has globally proven its high technology and capacity with FDC (fixed dose combinations) drugs. Amosartan, a hypertension drug, is exported to 51 countries around the world through Merck. Hanmi also develops and proceeds with many FDC drug projects with GSK.